Journal
SCIENCE
Volume 372, Issue 6542, Pages 635-+Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.abf9648
Keywords
-
Categories
Funding
- Sir Henry Dale Fellowship - Wellcome Trust [208812/Z/17/Z]
- Sir Henry Dale Fellowship - Royal Society [208812/Z/17/Z]
- Wellcome Trust Senior Research Fellowship
- Elrha's Research for Health in Humanitarian Crises (R2HC) Programme - UK Government (DFID)
- Wellcome Trust
- UK National Institute for Health Research (NIHR)
- BBSRC [LIDP BB/M009513/1]
- Bill & Melinda Gates Foundation [INV-001754, INV-003174, OPP1157270]
- NTD Modelling Consortium [OPP1184344, OPP1180644, OPP1183986]
- DFID/Wellcome Trust Epidemic Preparedness Coronavirus research program [221303/Z/20/Z]
- EDCTP2 [RIA2020EF-2983-CSIGN]
- ERC [757699]
- European Union's Horizon 2020 research and innovation program-project EpiPose [101003688]
- Global Challenges Research Fund (GCRF) project RECAP [ES/P010873/1]
- HDR UK [MR/S003975/1]
- MRC [MR/N013638/1]
- Nakajima Foundation
- National Institute for Health Research NIHR [16/136/46, 16/137/109]
- Health Protection Research Unit for Immunisation [NIHR200929]
- Health Protection Research Unit for Modelling Methodology [NIHR200929, HPRU-2012-10096, NIHR200908, PR-OD-1017-20002]
- Royal Society Dorothy Hodgkin Fellowship [RP\EA\180004]
- UK DHSC/UK Aid/NIHR [PR-OD-1017-20001]
- UK MRC [MC_PC_19065, MR/P014658/1]
- UK Public Health Rapid Support Team - United Kingdom Department of Health and Social Care
- Wellcome Trust [208812/Z/17/Z, 206250/Z/17/Z, 206471/Z/17/Z, 210758/Z/18/Z]
- Bill and Melinda Gates Foundation [INV-001754] Funding Source: Bill and Melinda Gates Foundation
- European Research Council (ERC) [757699] Funding Source: European Research Council (ERC)
- Wellcome Trust [206471/Z/17/Z] Funding Source: researchfish
Ask authors/readers for more resources
Slovakia conducted multiple rounds of population-wide rapid antigen testing for SARS-CoV-2 in late 2020, with observed prevalence decreasing by 58% within 1 week in counties subject to two rounds of mass testing. This decrease was not solely explained by infection control measures, but also required the isolation and quarantine of household members of those testing positive.
Slovakia conducted multiple rounds of population-wide rapid antigen testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in late 2020, combined with a period of additional contact restrictions. Observed prevalence decreased by 58% (95% confidence interval: 57 to 58%) within 1 week in the 45 counties that were subject to two rounds of mass testing, an estimate that remained robust when adjusting for multiple potential confounders. Adjusting for epidemic growth of 4.4% (1.1 to 6.9%) per day preceding the mass testing campaign, the estimated decrease in prevalence compared with a scenario of unmitigated growth was 70% (67 to 73%). Modeling indicated that this decrease could not be explained solely by infection control measures but required the addition of the isolation and quarantine of household members of those testing positive.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available